Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

139 BAY 57-9352: an inhibitor of VEGFR-2 and PDGFR receptor tyrosine kinases that demonstrates anti-angiogenic activity in vitro and in vivo

139 BAY 57-9352: an inhibitor of VEGFR-2 and PDGFR receptor tyrosine kinases that demonstrates... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Supplements CrossRef

139 BAY 57-9352: an inhibitor of VEGFR-2 and PDGFR receptor tyrosine kinases that demonstrates anti-angiogenic activity in vitro and in vivo

Elting, J.; Jones, R.; Carter, C.; Flynn, C.; Zhu, G.; Damico, C.; McHugh, M.; Hibner, B.; Kluender, H.; Boyer, S.
European Journal of Cancer Supplements , Volume 2 (8): 45 – Sep 1, 2004
Download PDF
Loading next page...
 
/lp/crossref/139-bay-57-9352-an-inhibitor-of-vegfr-2-and-pdgfr-receptor-tyrosine-OaGRYd7GLq

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CrossRef
ISSN
1359-6349
DOI
10.1016/s1359-6349(04)80147-2
Publisher site
See Article on Publisher Site

Abstract

Journal

European Journal of Cancer Supplements – CrossRef

Published: Sep 1, 2004

There are no references for this article.